These results confirm the potential of reducing adipogenic commitment and adipocyte hypertrophy in adipocyte progenitors, thus inhibiting the onset of obesity by a compound targeting S6K1 in AT [141,268]. The gene discussed is RPS6KB1; the disease is obesity disorder.